PRESS RELEASES

Year
March 30 | 2020
RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update
March 04 | 2020
RAPT Therapeutics Announces Management Promotions
February 19 | 2020
RAPT Therapeutics Announces Upcoming Investor Conference Presentations
February 07 | 2020
RAPT Therapeutics Announces Pricing of $75 Million Public Offering
February 04 | 2020
RAPT Therapeutics Announces Proposed Offering of Common Stock
January 07 | 2020
RAPT Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
December 16 | 2019
RAPT Therapeutics to be Added to the Russell 2000® and Russell Microcap® Indices
December 11 | 2019
RAPT Therapeutics Reports Third Quarter 2019 Financial Results and Recent Highlights
December 10 | 2019
RAPT Therapeutics Appoints Mary Ann Gray, Ph.D., to Board of Directors
December 04 | 2019
RAPT Therapeutics Appoints Rodney Young as Chief Financial Officer